by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Hangzhou Yiqi Biotechnology Co., Ltd Warning Letter Details

Warning Letter

Hangzhou Yiqi Biotechnology Co., Ltd

Hangzhou Yiqi Biotechnology Co., Ltd, Room 204, Building 3, No. 66 Xixiang Road, Puyan Street Hangzhou Shi Zhejiang Sheng , 310018 China

Issue DateApril 15, 2026

FEI Number3035145155

Violations3

CountryChina

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

Hangzhou Yiqi Biotechnology Co., Ltd FDA Warning Letter, April 15, 2026